Woodmont Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.6M | Buy |
22,183
+234
| +1% | +$239K | 1.45% | 16 |
|
|
2026
Q1 | $20.2M | Buy |
21,949
+1,129
| +5% | +$1.14M | 1.24% | 23 |
|
|
2025
Q4 | $22.4M | Buy |
20,820
+103
| +0.5% | +$98.5K | 1.4% | 16 |
|
|
2025
Q3 | $15.8M | Buy |
20,717
+807
| +4% | +$601K | 1.05% | 26 |
|
|
2025
Q2 | $15.5M | Buy |
19,910
+6,933
| +53% | +$5.39M | 1.02% | 23 |
|
|
2025
Q1 | $10.7M | Buy |
12,977
+2,290
| +21% | +$1.91M | 0.77% | 31 |
|
|
2024
Q4 | $8.25M | Buy |
10,687
+5,856
| +121% | +$4.85M | 0.61% | 39 |
|
|
2024
Q3 | $4.28M | Sell |
4,831
-41
| -0.8% | -$36.9K | 0.32% | 63 |
|
|
2024
Q2 | $4.41M | Buy |
4,872
+37
| +0.8% | +$29.6K | 0.36% | 56 |
|
|
2024
Q1 | $3.76M | Buy |
4,835
+74
| +2% | +$52.7K | 0.32% | 62 |
|
|
2023
Q4 | $2.78M | Buy |
4,761
+237
| +5% | +$138K | 0.26% | 77 |
|
|
2023
Q3 | $2.43M | Sell |
4,524
-92
| -2% | -$47.4K | 0.26% | 81 |
|
|
2023
Q2 | $2.16M | Sell |
4,616
-415
| -8% | -$174K | 0.22% | 84 |
|
|
2023
Q1 | $1.73M | Buy |
5,031
+310
| +7% | +$105K | 0.18% | 99 |
|
|
2022
Q4 | $1.73M | Hold |
4,721
| – | – | 0.2% | 98 |
|
|
2022
Q3 | $1.53M | Sell |
4,721
-50
| -1% | -$15.8K | 0.19% | 99 |
|
|
2022
Q2 | $1.55M | Buy |
4,771
+200
| +4% | +$60K | 0.19% | 101 |
|
|
2022
Q1 | $1.31M | Sell |
4,571
-625
| -12% | -$161K | 0.15% | 112 |
|
|
2021
Q4 | $1.44M | Hold |
5,196
| – | – | 0.18% | 100 |
|
|
2021
Q3 | $1.2M | Sell |
5,196
-30
| -0.6% | -$7.4K | 0.17% | 101 |
|
|
2021
Q2 | $1.2M | Hold |
5,226
| – | – | 0.19% | 95 |
|
|
2021
Q1 | $976K | Buy |
5,226
+15
| +0.3% | +$2.93K | 0.17% | 102 |
|
|
2020
Q4 | $880K | Buy |
5,211
+430
| +9% | +$64.2K | 0.16% | 102 |
|
|
2020
Q3 | $708K | Sell |
4,781
-50
| -1% | -$7.74K | 0.15% | 109 |
|
|
2020
Q2 | $793K | Sell |
4,831
-75
| -2% | -$11.5K | 0.19% | 100 |
|
|
2020
Q1 | $681K | Sell |
4,906
-325
| -6% | -$44.7K | 0.19% | 101 |
|
|
2019
Q4 | $688K | Hold |
5,231
| – | – | 0.16% | 112 |
|
|
2019
Q3 | $585K | Sell |
5,231
-200
| -4% | -$22.3K | 0.14% | 118 |
|
|
2019
Q2 | $602K | Buy |
5,431
+325
| +6% | +$38.3K | 0.15% | 115 |
|
|
2019
Q1 | $663K | Sell |
5,106
-750
| -13% | -$91.2K | 0.17% | 114 |
|
|
2018
Q4 | $678K | Sell |
5,856
-60
| -1% | -$6.7K | 0.19% | 106 |
|
|
2018
Q3 | $635K | Sell |
5,916
-75
| -1% | -$7.5K | 0.17% | 110 |
|
|
2018
Q2 | $511K | Sell |
5,991
-250
| -4% | -$20.5K | 0.14% | 118 |
|
|
2018
Q1 | $483K | Sell |
6,241
-264
| -4% | -$21.3K | 0.13% | 126 |
|
|
2017
Q4 | $549K | Hold |
6,505
| – | – | 0.14% | 129 |
|
|
2017
Q3 | $556K | Buy |
6,505
+89
| +1% | +$7.3K | 0.15% | 124 |
|
|
2017
Q2 | $528K | Hold |
6,416
| – | – | 0.15% | 123 |
|
|
2017
Q1 | $472K | Hold |
6,416
| – | – | 0.14% | 131 |
|
|
2016
Q4 | $472K | Buy |
6,416
+339
| +6% | +$25.2K | 0.14% | 135 |
|
|
2016
Q3 | $488K | Sell |
6,077
-42
| -0.7% | -$3.36K | 0.14% | 134 |
|
|
2016
Q2 | $482K | Sell |
6,119
-252
| -4% | -$19K | 0.14% | 138 |
|
|
2016
Q1 | $459K | Hold |
6,371
| – | – | 0.14% | 132 |
|
|
2015
Q4 | $537K | Sell |
6,371
-250
| -4% | -$20.7K | 0.16% | 129 |
|
|
2015
Q3 | $554K | Sell |
6,621
-200
| -3% | -$16.9K | 0.17% | 128 |
|
|
2015
Q2 | $569K | Sell |
6,821
-100
| -1% | -$7.62K | 0.16% | 127 |
|
|
2015
Q1 | $503K | Sell |
6,921
-800
| -10% | -$57K | 0.16% | 127 |
|
|
2014
Q4 | $533K | Hold |
7,721
| – | – | 0.16% | 128 |
|
|
2014
Q3 | $501K | Sell |
7,721
-250
| -3% | -$15.8K | 0.14% | 148 |
|
|
2014
Q2 | $496K | Sell |
7,971
-41
| -0.5% | -$2.45K | 0.14% | 151 |
|
|
2014
Q1 | $472K | Sell |
8,012
-200
| -2% | -$11.2K | 0.14% | 152 |
|
|
2013
Q4 | $419K | Buy |
8,212
+2,175
| +36% | +$109K | 0.13% | 150 |
|
|
2013
Q3 | $304K | Buy |
6,037
+350
| +6% | +$18.3K | 0.11% | 142 |
|
|
2013
Q2 | $279K | Buy |
+5,687
| New | +$309K | 0.09% | 174 |
|
Other funds holding LLY
SC
Woodmont Investment Counsel's LLY Position: Q2 2026 in Review
Woodmont Investment Counsel increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $239K and bringing the position to 22,183 shares worth $26.6M. The position accounts for 1.45% of the portfolio, ranked #16.
Woodmont Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 2,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Woodmont Investment Counsel held 22,183 shares of Eli Lilly worth $26.6M as of Q2 2026.
- Woodmont Investment Counsel bought 234 Eli Lilly shares in Q2 2026, an estimated $239K.
- Eli Lilly made up 1.45% of Woodmont Investment Counsel's portfolio in Q2 2026, its #16 holding.
- Woodmont Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 2,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Woodmont Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.